For example, studies have found that injection of IL-33 in AD transgenic mice enhanced Aβ clearance by reprogramming microglia epigenetics and transcriptome profiling, thereby alleviating AD pathology (Lau et al., 2020). Here, IL33 is linked to Alzheimer disease.